Ever-increasing emergence of multi-drug resistant Staphylococcus pseudintermedius in the dog and its zoonotic potentials by PAPADOGIANNAKIS (Ε. ΠΑΠΑΔΟΓΙΑΝΝΑΚΗΣ), E. et al.
   
   




  Ever-increasing emergence of multi-drug resistant






















  Copyright © 2018 E REFERENCES, E
VELONAKIS, A VATOPOULOS 
   
  
   
To cite this article:
PAPADOGIANNAKIS (Ε. ΠΑΠΑΔΟΓΙΑΝΝΑΚΗΣ), E., VELONAKIS (E. ΒΕΛΟΝΑΚΗΣ), E., & VATOPOULOS (Α.
ΒΑΤΟΠΟΥΛΟΣ), A. (2018). Ever-increasing emergence of multi-drug resistant Staphylococcus pseudintermedius in the
dog and its zoonotic potentials. Journal of the Hellenic Veterinary Medical Society, 67(2), 109-116.
doi:https://doi.org/10.12681/jhvms.15629
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:44:48 |
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:44:48 |
Corresponding author: E. I. Papadogiannakis DVM, CertSAD, PhD
Department of Veterinary Public Health, National School of Public Health, 
196 Alexandras Avenue, 115 21, Athens, Greece
E-mail:dermpap1@otenet.gr
Date of initial submission: 01.06.2015
Date of revised submission: 23.10.2015
Date of acceptance: 30.11.2015
 
ABSTRACT. Methicillin-resistant Staphylococcus pseudintermedius (MRSP) has emerged as an important pathogen in 
the dog over the past 10 years with an ever increasing incidence worldwide. This review focuses mainly on the epidemiology 
and detection of MRSP, emphasizing on the interpretation and pitfalls of screening laboratory tests and antimicrobial suscepti-
bility tests. Risk factors for colonization and infection with MRSP and molecular analysis of the dominant clonal lineages are 
also described. The zoonotic potential and worldwide epidemiology of multidrug resistant Staphylococcus pseudintermedius 
(MDRSP) are presented. Finally, control options for the colonization of healthy dogs as well as infection by MRSP and MDRSP 
are described emphasizing on the indications for bacterial culture and susceptibility testing and the principles of topical therapy 
which may prove to be the sole effective treatment in several canine pyoderma cases. 
Keywords: multi-drug resistant Staphylococcus pseudintermedius, dog, Public Health significance
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INTRODUCTION
Staphylococcus pseudintermedius is a commensal and, by far, the most common and important bacterial 
pathogen of the canine skin that has mainly been 
associated with the superficial and deep pyoderma. In 
many instances, pyoderma has been linked to poorly 
or even well controlled allergic diseases, most notably 
canine atopic dermatitis. S. pseudintermedius is also a 
leading cause of ear infections, those of other body tissues 
and cavities, and post-operative wound infections in dogs 
(Weese and van Duijkeren, 2010). S. pseudintermedius 
colonizes, in particular, mucocutaneous sites such as 
nares, mouth, anus, as well as groin and forehead of 
clinically healthy dogs (Devriese and De Pelsmaecker, 
1987; Griffeth et al., 2008; Siak et al., 2014). The reported 
prevalence of S. pseudintermedius carriage in healthy 
dogs range from 46% to 92% depending on the animal 
population and methodology applied (Bannoehr and 
Guardabassi, 2012). 
At the present, all staphylococcal strains isolated 
from dogs is suggested to be reported as S. pseudin-
termedius, unless genomic analysis proves otherwise 
(Devriese et al., 2009). 
METHICILLIN-RESISTANT S. PSEUDINTER-
MEDIUS (MRSP)
Methicillin-resistance reflects the expression of 
mecA gene coding for a modified penicillin-bind-
ing cell wall protein (PBP2a) whose low affinity for 
β-lactam antibiotics makes penicillins and cephalo-
sporins less effective (Loeffler et al., 2007). MecA 
gene is located within the staphylococcal chromosomal 
cassette mec, (SCCmec), a large and mobile genetic ele-
ment (Bond and Loeffler, 2012). Acquisition of SCCmec 
by S. pseudintermedius strains has led to the emergence 
of MRSP all over Europe (Loeffler et al., 2007; Ruscher 
et al., 2009; Perreten et al., 2010). An increasing number 
of studies have documented the rapid spread of MRSP 
worldwide (Perreten et al., 2010; Ruscher et al., 2010; 
Feng et al., 2012; Wang et al., 2012; Bardiau et al., 2013). 
In the U.S, MRSP has been identified in 57 out of 
336 isolates (17%) over one-year (Morris et al., 2006) 
whereas the figure dropped to 1 out of 25 (4%) in the 
1995 to 1998 period (Gortel et al., 1999). In Europe, 
MRSP accounted for 23% of S. pseudintermedius 
isolates from a dermatology practice (Loeffler et al., 
2007). In an Italian study, MRSP accounted for 10 out 
of 48 Staphylococcus intermedius group (SIG) isolates 
(21%), all of which were resistant to fluoroquinolones, 
gentamicin, lincosamides, tetracyclines and potentiat-
ed-sulphonamides (De Lucia et al., 2011), thus reflect-
ing the acquisition of additional resistance genes. In 
Greece, the resistance of S. intermedius (most likely 
S. pseudintermedius based on the new classification) 
isolates originating from 53 natural cases of canine 
pyoderma was found to be 0% for amoxicillin/clavu-
lanate, 11.3% for oxacillin, 7.5% for cefalexin, 5.7% 
for enrofloxacin, 32.1% for erythromycin, 11.3% for 
tylosin, 20.8% for lincomycin, 18.9% for clindamy-
cin, 32.1% for doxycycline, 5.7% for amicacin, 7.5% 
for chloramphenicol and 92.5% for trimethoprim/
ΠΕΡΙΛΗΨΗ. Ανθεκτικά στη μεθικιλλίνη στελέχη του Staphylococcus pseudintermedius (MRSP) έχουν εμφανιστεί στο 
σκύλο τα τελευταία 10 χρόνια, με ολοένα αυξανόμενη συχνότητα σε ολόκληρο τον κόσμο. Η βιβλιογραφική αυτή ανασκόπηση 
στοχεύει στην επιδημιολογία και ταυτοποίηση του MRSP και ιδιαίτερα στην ερμηνεία και τις παγίδες που ενδέχεται να κρύβουν 
οι εργαστηριακές δοκιμές ανίχνευσης και αντιμικροβιακής ευαισθησίας. Ακολουθεί η περιγραφή των παραγόντων κινδύνου 
για τον αποικισμό και την λοίμωξη από τον MRSP και η μοριακή ανάλυση των κυρίαρχων κλώνων. Επιπλέον, επισημαίνεται 
η σημασία που έχει ο πολυανθεκτικός στα αντιβιοτικά Staphylococcus pseudintermedius (MDRSP) για τη Δημόσια Υγεία, από 
επιδημιολογική άποψη. Αναφέρονται και οι επιλογές ελέγχου του αποικισμού των κλινικά υγιών σκύλων από τον MRSP και των 
νοσοκομειακών λοιμώξεων από τους MRSP και MDRSP. Τέλος, αναφέρεται το που και πότε πρέπει να γίνεται βακτηριδιακή 
καλλιέργεια και αντιβιόγραμμα και οι αρχές της τοπικής αντισταφυλοκοκκικής θεραπείας η οποία σε πολλά περιστατικά 
πυοδέρματος του σκύλου είναι η μοναδική θεραπευτική επιλογή του κτηνιάτρου. 
Λέξεις ευρετηριασμού: ανθεκτικός στη μεθικιλλίνη, πολυανθεκτικός στα αντιβιοτικά, Staphylococcus pseudintermedius, σκύλος, 
Δημόσια Υγεία. 
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sulfamethoxazole (Saridomichelakis et al., 2002). The 
authors have also isolated MRSP strains from a few 
canine pyoderma cases in Athens, Greece, over the 
last two years. 
Human and veterinary diagnostic laboratories 
commonly use phenotypic methods for the detection 
of MRSP/MRSA strains. The use of oxacillin disk 
diffusion along with the interpretative criteria applied 
to Staphylococcus aureus has led to a high percentage 
of false-negative results thus making it rather inappro-
priate as a screening tool (Bemis et al., 2009). In 2009, 
the Clinical and Laboratory Standards Institute (CLSI) 
of Veterinary Antimicrobial Susceptibility Testing 
(VAST) subcommittee re-evaluated the interpretative 
criteria, proposing an oxacillin MIC of ≥0.5 mg/L (agar 
and broth dilution) and a zone diameter of ≤17 mm (disc 
diffusion) as highly reliable for the detection of mecA 
in S. pseudintermedius strains (Papich, 2010). 
In antimicrobial susceptibility interpretation, the fact 
that methicillin resistance is mediated by mecA gene, 
that confers resistance to all β-lactam antibiotics, should 
be taken into account, regardless of the in vitro results 
(Jones et al., 2007). The same applies to macrolides 
because of their cross-resistance (Ganiere et al., 2005). 
In inducible clindamycin resistance (iCR) the responsible 
gene is not expressed until the exposure to this antibiotic, 
thus complicating the interpretation of susceptibility test-
ing; this has been associated, though uncommonly, with 
MRSP (Rubin et al., 2011). S. pseudintermedius isolates 
that are resistant to other macrolides (e.g erythromycin) 
but not to clindamycin should be tested for the presence 
of iCR either by D-test or genetic testing, because if not 
there is increased risk for treatment failures (Gold and 
Lawhon 2013). Before the emergence of MRSP, most of 
S. pseudintermedius infections in dogs were successfully 
managed with empirical or based on culture and suscep-
tibility testing antibacterial treatment. 
Interestingly, PBP2a latex agglutination test, 
developed for methicillin-resistant S. aureus (MRSA) 
in humans may result in false-positive results when 
applied to S. pseudintermedius isolates, thus making it 
unacceptable as a sole test to confirm the presence of 
MRSP (Pottumarthy et al., 2004).
MRSP strains have been isolated from dogs, cats 
and humans (Wettstein et al., 2008; Hanselman et al., 
2009), in situations associated with contamination, 
colonization or infection (van Duijkeren et al., 2011). 
Despite the restricted number of studies on the risk 
factors for MRSP colonization or infection the use of 
antibiotics in hospitalization and surgeries have been 
so far incriminated (Sasaki et al., 2007; Weese et al., 
2009; Nienhoff et al. 2011). Busy practice and treatment 
with ear medications or glucocorticoids are also hold 
responsible for such an infection (Lehner et al., 2014). 
Molecular analyses have greatly facilitated the 
epidemiological and evolutionary studies regarding the 
origin and spread of MRSP (van Duijkeren et al., 2011; 
Chanchaithong and Prapasarakul, 2011). A certain num-
ber of MRSP strains are resistant to antibiotics usually 
applied in the everyday practice, notably ST71 in Europe 
and ST68 in North America (Osland et al., 2012). In vitro 
conditions, MRSP ST71 strain has an increased adher-
ence to canine and human corneocytes than the other 
MRSP strains and the methicillin susceptible S. pseud-
intermedius (MSSP) strains (Paul et al., 2011; Latronico 
et al., 2014). This enhanced adherence of ST71 may 
contribute to the epidemiological success of the MRSP 
ST71, most likely due to its higher ability to adapt to 
human epidermis, that may explain the expanded host 
spectrum and zoonotic significance (Paul et al., 2011).
MULTI-DRUG RESISTANT S. PSEUDINTERME-
DIUS (MDRSP)
In veterinary medicine, multi-drug resistance 
(MDR) is of major concern (Frank and Loeffler, 2012). 
MDR is defined as resistance developed to three, at 
least, different classes of antimicrobials in addition to 
β-lactams (Coombs et al., 2004). In a recent study on a 
total of 1069 S. pseudintermedius isolates, 4.5% were 
MRSP and 27.5% MDR (Detwiller et al., 2013). In a 
large study including 103 staphylococcal isolates and 
originating from North America and Europe, 90% were 
resistant to ciprofloxacin, clindamycin, erythromycin, 
kanamycin, streptomycin and trimethoprim, 70% to 
gentamicin and tetracycline and 57% to chlorampheni-
col in addition to their resistance to β-lactam antibiotics 
(Perreten et al., 2010); in Germany, the resistance rates 
to fluoroquinolones, aminoglycosides and macrolides 
have been higher (Ruscher et al., 2009). Also, many 
MRSP isolates from north America are susceptible to 
chloramphenicol, rifampicin and amikacin; in Europe 
they are often resistant to chloramphenicol but suscepti-
ble to minocycline (Frank and Loeffler, 2012), although 
the explanation behind these geographical differences 
in MRSP is still lacking. These findings may lower the 
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chances for a successful systemic treatment especially 
in canine pyoderma cases. 
The fact that, MRSP Staphylococcus pseudin-
termedius strains have recently been isolated from 
various body sites in healthy dogs and cats (Davis et 
al., 2014), make their role as reservoirs of MDRSP 
possible as well as their ability to transfer to people 
interacting with animals.
ZOONOTIC IMPLICATIONS
It is very uncommon for Staphylococcus pseudinter-
medius to colonize the human skin, but carriage rates are 
generally higher in people interacting with dogs (Harvey 
et al., 1994; Goodacre et al., 1997; Guardabassi et al., 
2004). S. pseudintermedius isolates are an uncommon 
occurrence in human hospitals (Mahoudeau et al., 1997), 
although the initial misidentification of S. pseudinterme-
dius as S. aureus was a matter of concern (Tanner et al., 
2000; Potthumarthy et al., 2004; Kempker et al., 2009). 
In particular, S. pseudintermedius is normally negative 
by rapid slide clumping factor test and commercial latex 
agglutination test, both detecting the clumping factor, 
protein A and/or surface antigens of S. aureus (Banner-
man, 2003). Phenotypic tests that help to differentiate S. 
pseudintermedius from the other staphylococcal species 
in the dog include coagulase, acetoin production, pyrro-
lidonyl arylamidase, b-galactosidase, polymyxin B resis-
tance and D-mannitol acidification (Bannerman, 2003).
Nasal carriage of S. pseudintermedius was not 
demonstrated in any of 56 healthy human volunteers, 
in contrast to dental plaques with a figure as high as 
8.9% (Ohara-Nemoto et al., 2008). Nasopharyngeal 
colonization of less than 1.5% has been reported in the 
academic veterinary staff (Talan et al., 1989; Loeffler et 
al., 2005). However, in more recent studies the rates were 
higher among dog owners. In particular, 1 persistent and 
4 temporary nasal carriers of Staphylococcus “interme-
dius” were identified in 16 owners with atopic dogs and 
in 13 veterinary practice members (Harvey et al., 1994). 
The strains recovered from humans were in general 
correlated with those obtained from the in-contact dogs 
(Goodacre et al., 1997). S. pseudintermedius was also 
isolated from 9 out of 24 (37,5%) small animal owners, 
in which 4 carried the strain isolated from their dogs 
(Hanselman et al., 2009). Also, nasal carriage rates of S. 
pseudintermedius were higher among owners with dogs 
suffering from deep pyoderma, although this has been 
shown to be a temporary colonization (Guardabassi et 
al., 2004; Frank et al., 2009). Regarding MRSP strains, 
the recognition of carriage among humans in contact 
with dogs was lower as well as that of sporadic human 
infections (Gerstadt et al., 1999, Campanile et al., 2007, 
Kempker et al., 2009, Stegmann et al., 2010). 
Whereas the staphylococcal colonization of humans 
is transient after their exposure to S. pseudintermedius 
of canine origin, after the establishment of the corre-
sponding infection it is difficult to eradicate (Stegmann 
et al., 2010). Interestingly, human carriage rates of 
MRSP are higher than that of MSSP, possibly reflect-
ing the in-contact risk in both veterinarians and dog 
owners (Loeffler et al., 2010). Furthermore, MRSP of 
canine origin is considered a potential source of SCC-
mec transfer and perhaps other mobile determinants of 
antimicrobial resistance to staphylococcal nomads in 
human skin and mucosae (Guardabassi et al., 2004).
CONTROL OPTIONS FOR COLONIZED 
HEALTHY DOGS
Due to MRSP carriage potential in clinically 
healthy dogs (Davis et al., 2014), all the necessary 
precautions should be taken whenever a close contact 
with them is anticipated. Most likely, dogs colonized 
with MRSP are of greater risk to develop relevant 
infections especially when are wounded or undergone 
antimicrobial therapy. These animals should be washed 
with chlorhexidine-containing shampoos, in an effort 
to decontaminate the hair coat and skin. Long-standing 
colonization with MRSP may occur because dogs are 
natural hosts of S. pseudintermedius (van Duijkeren et 
al., 2011). Cleaning and disinfection of the house will 
probably help to prevent re-colonization from contam-
inated sources. At the present, there is no scientific 
evidence regarding the effectiveness of antibiotics to 
clear MRSP colonization in the dog.
INFECTION CONTROL IN VETERINARY 
PRACTICE
Successful control of MRSP and/or MDRSP infec-
tion/contamination is based on personal and environmen-
tal hygiene. Due to the fact that staphylococci are usually 
transmitted via hand contact, relevant hygiene is critical 
for the prevention of MRSP spread, as well. Also, envi-
ronmental cleaning and disinfection play an important 
role, as MRSA carriage in rescue kennels for dogs has 
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reportedly been eliminated as soon as regular cleaning 
of the facilities was instituted (Loeffler et al., 2010a). 
Environmental hygiene is also important as MRSP was 
being isolated over a 6 month period from households 
after the resolution of MRSP infection in the residing 
pets (Laarhoven et al., 2011). These measures will limit 
the spread of MRSP from infected patients and unrecog-
nized carriers and help to prevent nosocomial infections 
in the setting of veterinary practice (Frank and Loeffler, 
2012). In addition, isolation procedures within veterinary 
practices are warranted, because healthy dogs in contact 
with MRSP-infected dogs showed unusually high (36%) 
MRSP carriage rates (van Duijkeren et al., 2011). 
In general, routine measures aiming at reducing 
the risk for antimicrobial resistance include a) hand 
washing and disinfection of surfaces and equipment 
in-between patient handling. Alcohol gel pouches can 
be used immediately after any contact with dogs. Alco-
hol is not effective in the presence of organic material, 
thus necessitating its removal by hand washing with 
a detergent. b) avoid materials at hand touch sites that 
cannot be cleaned (e.g. use washable keyboards or key-
board covers in computers) c) cover skin wounds and 
excoriations with waterproof dressings d) apply aseptic 
techniques and high standard cleaning e) dispose all 
waste and contaminated material and f) make sure that 
the veterinary staff understand and adhere to infection 
control measures (Nuttal et al., 2008). 
In all cases of poorly responsive canine pyoderma 
to empiric therapy, bacterial culture and susceptibility 
testing are recommended along with treatment compli-
ance. Culture is also recommended in patients with 
deep pyoderma and suspected concurrent infection with 
Gram-negative bacteria, atypical bacterial infection 
(e.g Mycobacterium, Actinomyces, Nocardia), severe 
or life-threatening infections and frequently relapsing 
pyoderma (Vitale, 2014). In general, the recommended 
duration of treatment is approximately 3 weeks for 
superficial and 4-6 weeks for deep canine pyoderma. 
The length of antibiotic administration should be 7 days 
past clinical remission in uncomplicated infections and 
10-14 days past clinical remission in complicated infec-
tions, such as recurrent or deep pyoderma and those 
associated with immunosuppression (Frank and Loef-
fler, 2012). Treatment protocols of shorter duration may 
contribute to the emergence of MRSP strains. 
Topical treatment may be used as a sole therapy 
in recurrent pyoderma cases and particularly in those 
caused by MRSP, where the choices for systemic anti-
biotic therapy are limited and/or the adverse reactions 
to systemic medications are prohibiting. Shampoos 
containing chlorexidine, benzoyl peroxide or ethyl 
lactate have all demonstrated high efficacy in dogs 
with staphylococcal infections, although chlorexidine 
should be preferred in MRSP-induced infections (Siak 
et al., 2014). Antibacterial bathing should be practiced 
3 times per week, with 10 min contact time for bet-
ter results (Murayama et al., 2011). Focal lesions can 
be treated with chlorexidine spray, mupirocin oint-
ment, benzoyl peroxide gel, fusidic acid ointment or 
nisin (Werner and Russel, 1999). As is the case with 
any antimicrobial, prudent use of topical products is 
advised to prevent widespread resistance.
CONCLUDING REMARKS
An increasing number of studies have documented 
the rapid spread of MRSP, worldwide. Several screen-
ing tests, used by human and many veterinary diagnos-
tic laboratories, for the detection of methicillin resist-
ance in staphylococci, may lead to a high percentage 
of false-negative or false-positive results. 
Furthermore, when interpreting antimicrobial 
susceptibility results it should be kept in mind that 
methicillin resistance includes cephalosporins and 
amoxicillin-clavulanate, regardless of the in vitro 
results. S. pseudintermedius isolates that are resistant 
to macrolides, such as erythromycin, but susceptible 
to clindamycin should be tested for the presence of 
inducible clindamycin resistance, because the latter 
phenomenon may result in treatment failures.
Prior hospitalization and antibiotic treatment are 
usually associated with MRSP colonization and infec-
tion in dogs. Canine-derived MRSP should be con-
sidered as a potential source for SCCmec transfer and 
possibly other mobile determinants of antimicrobial 
resistance to susceptible staphylococci on human skin 
and mucosae. Identification of S. pseudintermedius as 
S. aureus is rather common misdeed in medical labo-
ratories, used to deal with the latter species.
Successful control of MRSP contamination or infec-
tion are mainly based on hand and environmental hygiene.
CONFLICT OF INTEREST STATEMENT
None declared. 
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:44:48 |
114 PAPADOGIANNAKIS E., VELONAKIS E., VATOPOULOS A.
J HELLENIC VET MED SOC 2016, 67(2)
ΠΕΚΕ 2016, 67(2)
Bannerman TL (2003) Staphylococcus, Micrococcus and other 
Gram-positive cocci that grow aerobically. Manual of Clinical 
Microbiology. Washington, DC: American Society for 
Microbiology, pp:384-404.
Bannoehr J, Guardabassi L (2012) Staphylococcus pseudinterme-
dius in the dog: taxonomy, diagnostics, ecology, epidemiology 
and pathogenicity. Veterinary Dermatology 23:253–266.
Bardiau M, Yamazaki K, Ote I, Misawa N, Mainil JG (2013) 
Characterization of methicillin-resistant Staphylococcus 
pseudintermedius isolated from dogs and cats. Microbiology 
Immunology 57: 496–501.
Bemis DA, Jones RD, Frank LA, et al (2009) Evaluation of sus-
ceptibility test breakpoints used to predict mecA-mediated 
resistance in Staphylococcus pseudintermedius isolated from 
dogs. Journal of Veterinary Diagnostic Investigation 21: 53-58.
Bond R, Loeffler A (2012) What’s happened to Staphylococcus 
intermedius? Taxonomic revision and emergence of multi-
drug resistance. Journal of Small Animal Practice 53:147-154.
Campanile F, Bongiorno D, Borbone S, Venditti M, Giannella M, 
Franchi C, Stefani S (2007) Characterization of a variant of the 
SCCmec element in a bloodstream isolate of Staphylococcus 
intermedius. Microbial Drug Resistance 13: 7-10.
Chanchaithong P, Prapasarakul N (2011) Biochemical markers 
and protein pattern analysis for canine coagulase-positive 
staphylococci and their distribution on dog skin. Journal of 
Microbiological Methods 86: 175-181.
Coombs GW, Nimmo GR, Bell JM, Huygens F, O’Brien FG, 
Malkowski MJ, Pearson JC, Stephens AJ, Giffard PM (2004) 
Genetic diversity among community methicillin-resistant 
Staphylococcus aureus strains causing outpatient infections 
in Australia. Journal of Clinical Microbiology 42: 4735-4743.
Davis JA, Jackson CR, Fedorka-Cray PJ, Barrett JB, Brousse JH, 
Gustafson J, Kucher M (2014) Carriage of methicillin-resis-
tant staphylococci by healthy companion animals in the US. 
Letters in Applied Microbiology 59: 1-8.
De Lucia M, Moodley A, Latronico F et al (2011) Prevalence of 
canine methicillin resistant Staphylococcus pseudintermedi-
us in a veterinary diagnostic laboratory in Italy. Research in 
Veterinary Science 91: 346–348.
Detwiler A, Bloom P, Petersen A, Rosser EJ Jr (2013) Multi-
drug and methicillin resistance of staphylococci from canine 
patients at a veterinary teaching hospital (2006-2011). 
Veterinary Quarterly 33: 60-67.
Devriese LA, De Pelsmaecker K. (1987) The anal region as a main 
carrier site of Staphylococcus intermedius and Streptococcus 
canis in dogs. Veterinary Record 121: 302–303.
Devriese LA, Hermans K, Baele M et al. (2009) Staphylococcus 
pseudintermedius versus Staphylococcus intermedius. 
Veterinary Microbiology 133: 206–207.
REFERENCES 
Feng Y, Tian W, Lin D, Luo Q, Zhou Y, Yang T, Deng Y, Liu YH, 
Liu JH (2012) Prevalence and characterization of methicil-
lin-resistant Staphylococcus pseudintermedius in pets from 
South China. Veterinary Microbiology 160:517–524.
Frank LA, Kania SA, Kirzeder EM et al. (2009) Risk of colo-
nization or gene transfer to owners of dogs with meticil-
lin-resistant Staphylococcus pseudintermedius. Veterinary 
Dermatology 20: 496–501.
Frank LA, Loeffler A (2012) Meticillin-resistant Staphylococcus 
pseudintermedius: clinical challenge and treatment options. 
Veterinary Dermatology 23:283-291.
Ganiere JP, Medaille C, Mangion C (2005) Antimicrobial drug 
susceptibility of Staphylococcus intermedius clinical isolates 
from canine pyoderma. J Vet Med 52: 25–31.
Gerstadt K, Daly JS, Mitchell M, Wessolossky M, Cheeseman SH 
(1999) Methicillin-resistant Staphylococcus intermedius pneu-
monia following coronary artery bypass grafting. Clinical 
Infectious Diseases 29: 218-219.
Gold RM and Lawhom SD (2013) Incidence of inducible clinda-
mycin resistance in Staphylococcus pseudintermedius from 
dogs. Journal of Clinical Microbiology 51: 4196-4199.
Goodacre R, Harvey R, Howell SA, Leighton W. Greenham LW, 
Noble WC (1997) An epidemiological study of Staphylococcus 
intermedius strains isolated from dogs, their owners and vet-
erinary surgeons. Journal of Analytical and Applied Pyrolysis 
44: 49–64.
Gortel K, Campbell KL, Kakoma I, Whittem T, Schaeffer DJ, 
Weisiger RM (1999) Methicillin resistance among staphy-
lococci isolated from dogs. American Journal of Veterinary 
Research 60:1526–1530.
Griffeth GC, Morris DO, Abraham JL, Shofer FS, Rankin SC 
(2008) Screening for skin carriage of methicillin-resis-
tant coagulase-positive staphylococci and Staphylococcus 
schleiferi in dogs with healthy and inflamed skin. Veterinary 
Dermatology 19:142-149.
Guardabassi L, Loeber ME, Jacobson A (2004) Transmission of 
multiple antimicrobial-resistant Staphylococcus intermedius 
between dogs affected by deep pyoderma and their owners. 
Veterinary Microbiology 98: 23–27.
Hanselman BA, Kruth SA, Rousseau J et al. (2009) Coagulase 
positive staphylococcal colonization of humans and their 
household pets. Canadian Veterinary Journal 50: 954–958.
Harvey RG, Marpless RR, and Noble WC (1994) Nasal Carriage of 
Staphylococcus interrnedius in Humans in Contact with Dogs. 
Microbial Ecology in Health and Disease 7: 225-227.
Jones RD, Kania SA, Rohrbach BW et al. (2007) Prevalence of 
oxacillin and multidrug-resistant staphylococci in clinical 
samples from dogs: 1,772 samples (2001–2005). J Am Vet Med 
Assoc 230: 221–227.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:44:48 |
ΠΑΠΑΔΟΓΙΑΝΝΑΚΗΣ Ε., ΒΕΛΟΝΑΚΗΣ Ε., ΒΑΤΟΠΟΥΛΟΣ Α.  115
J HELLENIC VET MED SOC 2016, 67(2)
ΠΕΚΕ 2016, 67(2)
Kempker R, Mangalat D, Kongphet-Tran T et al (2009) Beware of 
the pet dog: a case of Staphylococcus intermedius infection. 
The American Journal of Medical Sciences 338: 425-427.
Laarhoven LM, de Heus P, van Luijn J, Duim B, Wagenaar JA, van 
Duijkeren E (2011) Longitudinal study on methicillin-resistant 
Staphylococcus pseudintermedius in households. PLoS One 6: 
e27788.
Latronico F, Moodley A, Nielsen SS, Guardabassi L (2014). 
Enhanced adherence of methicillin-resistant Staphylococcus 
pseudintermedius sequence type 71 to canine and human cor-
neocytes. Veterinary Research 45:70.
Lehner G, Linek M, Bond R, Lloyd DH, Prenger-Berninghoff 
E, Thom N, Straube I, Verheyen K, Loeff ler A (2014) 
Case-control r isk factor study of methicillin-resistant 
Staphylococcus pseudintermedius (MRSP) infection in dogs 
and cats in Germany. Veterinary Microbiology 168: 154-60.
Loeff ler A, Boag AK, Sung J, Lindsay JA, Guardabassi 
L, Dalsgaard A, Smith H, Stevens KB, Lloyd DH (2005) 
Prevalence of methicillin-resistant Staphylococcus aureus 
among staff and pets in a small animal referral hospital in the 
UK. Journal of Antimicrobial Chemotherapy 56: 692-697.
Loeff ler A, Linek M, Moodley A, Guardabassi L, Sung JM, 
Winkler M, Weiss R, Lloyd DH (2007) First report of multire-
sistant, mecA-positive Staphylococcus intermedius in Europe: 
12 cases from a veterinary dermatology referral clinic in 
Germany. Veterinary Dermatology 18:412-421.
Loeffler A, Pfeiffer DU, Lindsay JA, Soares-Magalhaes R, Lloyd 
DH (2010) Lack of transmission of methicillin-resistant 
Staphylococcus aureus (MRSA) between apparently healthy 
dogs in a rescue kennel. Veterinary Microbiology 141:178-181.
Loeff ler A, Pfeiffer DU, Lloyd DH et al. (2010a) Meticillin-
resistant Staphylococcus aureus carriage in UK veterinary 
staff and owners of infected pets: newrisk groups. J Hosp 
Infect 2010; 74: 282–288.
Mahoudeau I, Delabranche X, Prevost G et al (1997) Frequency of 
isolation of Staphylococcus intermedius from humans. Journal 
of Clinical Microbiology 35: 2153-2154.
Morris DO, Rook KA, Shofer FS et al (2006) Screening of 
Staphylococcus aureus, Staphylococcus intermedius, and 
Staphylococcus schleiferi isolates obtained from small com-
panion animals for antimicrobial resistance: a retrospective 
review of 749 isolates (2003–04). Veterinary Dermatology 17: 
332-337.
Murayama N, Terada Y, Okuaki M et al. (2011) Contact time of 
2% chlorhexidine acetate for canine superficial pyoderma. Vet 
Dermatol 22: 449–453.
Nienhoff U, Kadlec K, Chaberny IF et al. (2011). Methicillin-
resistant Staphylococcus pseudintermedius among dogs admit-
ted to a small animal hospital. Vet Microbiol 150: 191–7.
Nuttall T, Williams N, Saunders R, Dawson S (2008) Meticillin-
resistant staphylococci in companion animals. European 
Journal of Companion Animal Practice 18: 280-287.
Ohara-Nemoto Y, Haraga H, Kimura S, Nemoto TK (2008) 
Occurrence of staphylococci in the oral cavities of healthy 
adults and nasal oral trafficking of the bacteria. Journal of 
Medical Microbiology 57: 95-99.
Osland AM, Vestby LK, Fanuelsen H, Slettemeås JS, Sunde M 
(2012) Clonal diversity and biofilm-forming ability of methi-
cillin-resistant Staphylococcus pseudintermedius. Journal of 
Antimicrobial Chemotherapy 67: 841-848.
Papich MG (2010) Proposed changes to Clinical Laboratory 
Standards Institute interpretive criteria for methicillin-resis-
tant Staphylococcus pseudintermedius isolated from dogs. 
Journal of Veterinary Diagnostic Investigation 22: 160.
Paul NC, Moodley A, Ghibaudo G, Guardabassi L (2011) Carriage 
of methicillin resistant Staphylococcus pseudintermedius 
in small animal veterinarians: indirect evidence of zoonotic 
transmission. Zoonoses and Public Health 58: 533-539.
Perreten V, Kadlec K, Schwarz S, Grönlund Andersson U, 
Finn M, Greko C, Moodley A, Kania SA, Frank LA, Bemis 
DA, Franco A, Iurescia M, Battisti A, Duim B, Wagenaar 
JA, van Duijkeren E, Weese JS, Fitzgerald JR, Rossano A, 
Guardabassi L (2010) Clonal spread of methicillin-resis-
tant Staphylococcus pseudintermedius in Europe and North 
America: an international multicentre study. Journal of 
Antimicrobial Chemotherapy 65: 1145-1154.
Pottumarthy S, Schapiro JM, Prentice JL et al (2004) Clinical 
isolates of Staphylococcus intermedius masquerading as meth-
icillin resistant Staphylococcus aureus. Journal of Clinical 
Microbiology 42: 5881-5884.
Rubin JE, Ball KR, Chirino-Trejo M (2011) Antimicrobial suscep-
tibility of Staphylococcus aureus and Staphylococcus pseudin-
termedius isolated from various animals. Can Vet J 52: 153–157.
Ruscher C, Lübke-Becker A, Wleklinski CG et al. (2009) 
Prevalence of methicillin-resistant Staphylococcus pseudinter-
medius isolated from clinical samples of companion animals 
and equidaes. Veterinary Microbiology 136: 197-201.
Ruscher C, Lübke-Becker A, Semmler T, Wleklinski CG, Paasch 
A, Soba A, Stamm I, Kopp P, Wieler LH, Walther B (2010) 
Widespread rapid emergence of a distinct methicillin- and multi-
drug-resistant Staphylococcus pseudintermedius (MRSP) genet-
ic lineage in Europe. Veterinary Microbiology 144: 340-346.
Saridomichelakis M.N., Koutinas A.F., Heliadis Ν., Georgopoulou I., 
Leontides L (2002) Antibiotic resistance of Staphylococcus inter-
medius strains isolated from 53 natural cases of canine pyoderma. 
Journal of Hellenic Veterinary Medical Society 53: 325-334.
Sasaki T, Kikuchi K, Tanaka Y et al. (2007) Methicillin-resistant 
Staphylococcus pseudintermedius in a veterinary teaching 
hospital. Journal of Clinical Microbiology 45: 1118-1125.
Siak M, Burrows AK, Coombs GW, Khazandi M, Abraham 
S, Norris JM, Weese JS, Trott DJ (2014) Characterization 
of meticillin-resistant and meticillin-susceptible isolates 
of Staphylococcus pseudintermedius from cases of canine 
pyoderma in Australia. Journal of Medical Microbiology 63: 
1228-1233.
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:44:48 |
116 PAPADOGIANNAKIS E., VELONAKIS E., VATOPOULOS A.
J HELLENIC VET MED SOC 2016, 67(2)
ΠΕΚΕ 2016, 67(2)
Stegmann R, Burnens A, Maranta CA, Perreten V (2010) Human 
infection associated with methicillin-resistant Staphylococcus 
pseudintermedius  ST71. Jou r nal  of  A nt imicrobia l 
Chemotherapy 65: 2047-2048.
Talan DA, Staatz D, Staatz A, Overturf GD (1989) Frequency of 
Staphylococcus intermedius as human nasopharyngeal flora. 
Journal of Clinical Microbiology 27: 2393.
Tanner MA, Everett CL, Youvan DC (2000) Molecular phylo-
genetic evidence of noninvasive zoonotic transmission of 
Staphylococcus intermedius from a canine pet to a human. 
Journal of Clinical Microbiology 38: 1628-1631.
van Duijkeren E, Catry B, Greko C et al [Scientific Advisory 
Group on Antimicrobials (SAGAM)] (2011) Review on meth-
icillin-resistant Staphylococcus pseudintermedius. Journal of 
Antimicrobial Chemotherapy 66: 2705-2714.
Vitale C (2014) Methicillin-Resistant Staphylococcal Infections. 
In: Current Veterinary Therapy XV, eds Bonagura and Twedt, 
Elsevier-Saunders, St Louis, MI, USA pp: 443-445.
Wang Y, Yang J, Logue CM, Liu K, Cao X, Zhang W, Shen J, Wu 
C (2012) Methicillin-resistant Staphylococcus pseudintermedi-
us isolated from canine pyoderma in North China. Journal of 
Applied Microbiology 112: 623-630.
Weese J, Frank LA, Reynolds LM et al. (2009). Retrospective 
study of methicillin-resistant and methicillin-suscepti-
ble S. pseudintermedius infections in dogs. Abstracts of the 
First ASM/ESCMID Conference on Methicillin-Resistant 
Staphylococci in Animals: Veterinary and Public Health 
Implications, London, UK, Washington, DC, USA: American 
Society for Microbiology: Abstract 43A.
Weese JS, van Duijkeren E (2010) Methicill in-resistant 
Staphylococcus aureus and Staphylococcus pseudintermedius 
in veterinary medicine. Vet Microbiol 140: 418-29.
Werner AH, Russel AD (1999) Mupirocin, fusidic acid and baci-
tracin: activity, action and clinical uses of three topical antibi-
otics. Vet Dermatol 10: 225–240.
Wettstein K, Descloux S, Rossano A, Perreten V (2008) 
Emergence of methicillin-resistant Staphylococcus pseudinter-
medius in Switzerland: three cases of urinary tract infections 
in cats. Schweiz Arch Tierheilkd 150: 339- 343.
Powered by TCPDF (www.tcpdf.org)
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 18/05/2020 02:44:49 |
